Necrotic enteritis is a devastating intestinal disease of poultry caused by Clostridium perfringens, a gram-positive, spore-forming anaerobic bacterium. This condition represents one of the most significant bacterial diseases affecting the global poultry industry, causing estimated economic losses exceeding six billion dollars annually through mortality, reduced growth performance, increased feed conversion, and costs associated with prevention and control. The disease predominantly affects broiler chickens between two and six weeks of age but also occurs in layer pullets, turkeys, and other poultry species worldwide.
Clostridium perfringens is ubiquitous in the poultry environment, found naturally in soil, litter, feed, and the intestinal tracts of healthy birds. The bacterium becomes pathogenic when environmental or host factors allow it to proliferate excessively in the small intestine and produce disease-causing toxins, particularly the NetB toxin that is essential for necrotic enteritis development. The transition from commensal organism to pathogen depends on complex interactions between bacterial virulence factors, intestinal conditions, host immunity, diet composition, and predisposing factors such as coccidiosis that damage the intestinal mucosa.
The economic impact of necrotic enteritis extends far beyond direct mortality losses. Clinical outbreaks can cause mortality rates ranging from two to fifty percent in affected flocks, but subclinical disease without obvious signs often causes greater total economic loss through impaired feed efficiency, reduced weight gain, and uneven flock performance. The withdrawal of antibiotic growth promoters in many countries has led to increased necrotic enteritis incidence, making alternative control strategies increasingly important. Condemnation of affected carcasses at processing, costs of therapeutic treatment, and economic impacts of preventive programs all contribute to the substantial financial burden this disease places on poultry producers.
Necrotic enteritis is treatable with antibiotics when diagnosed promptly, though prevention through management practices, dietary modifications, and alternatives to antibiotic growth promoters represents the most sustainable approach to control. Understanding the complex predisposing factors, recognizing clinical and subclinical disease presentations, and implementing comprehensive prevention programs enables producers to minimize losses from this challenging condition.
